Comments on: "Efficacy and Safety of Pregabalin for Restless Legs Syndrome in Korean Adults: A Randomized, Double-Blind, Placebo-Controlled Trial". [PDF]
Kalam F, Kamal A, Anwer M.
europepmc +1 more source
Numerical investigation of wake interaction and bio-inspired propulsive performance of tandem flapping foils for soft-robotic underwater locomotion. [PDF]
Swain PK +7 more
europepmc +1 more source
Green-synthesized CdTe quantum dots: dual-action nanomaterials tackling antimicrobial resistance and cancer. [PDF]
Golakiya P +11 more
europepmc +1 more source
The idea is that we can never understand each other because we come from different experiences and cultures. Most post-positivists are constructivists who believe that we each construct our view of the vforld based on our perceptions of it. Because perception and observation are fallible, our constructions must be imperfect.
openaire +1 more source
Child Hemoglobin Trajectories across the First 10 Years of Life and Association with Child Cognition and Academic Achievement at 10-11 Years. [PDF]
Young MF +6 more
europepmc +1 more source
The digital health revolution: transforming healthcare delivery through telemedicine in the post-pandemic era. [PDF]
Nawaz J, Rathi D, Kalam H.
europepmc +1 more source
Tonmya (cyclobenzaprine hydrochloride sublingual tablets): first FDA-approved therapy for fibromyalgia in over 15 years. [PDF]
Hujjat SFZ, Zahra SH, Abbas T, Kalam H.
europepmc +1 more source
Clinico-Etiological Study of Purpura Fulminans: Experience from a Tertiary-Care Children Hospital. [PDF]
Kalam S +4 more
europepmc +1 more source
Associations of Vitamin D Receptor (ApaI, FokI, TaqI, BsmI) Polymorphisms with Neurodegenerative Diseases in the Middle East, North Africa and Turkiye (MENA&T) Region: A Systematic Review and Meta-Analysis Toward Population-Specific Precision Medicine. [PDF]
Kalam AA +8 more
europepmc +1 more source
Tafasitamab (MOR208) in relapsed or refractory follicular lymphoma: a promising frontier in targeted immunotherapy. [PDF]
Ahmad M, Kalam H.
europepmc +1 more source

